This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fidel, P. L.
Right arrow Articles by Sobel, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fidel, P. L., Jr
Right arrow Articles by Sobel, J. D.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, Jul 1996, 335-348, Vol 9, No. 3
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Immunopathogenesis of recurrent vulvovaginal candidiasis

PL Fidel Jr and JD Sobel
Division of Infectious Diseases, Wayne State University School of Medicine, Detroit, Michigan 48201, USA. pFidel@NOMVS.LSUMC.edu

Recurrent vulvovaginal candidiasis (RVVC) is a prevalent opportunistic mucosal infection, caused predominantly by Candida albicans, which affects a significant number of otherwise healthy women of childbearing age. Since there are no known exogenous predisposing factors to explain the incidence of symptomatic vaginitis in most women with idiopathic RVVC, it has been postulated that these particular women suffer from an immunological abnormality that prediposes them to RVVC. Because of the increased incidence of mucosal candidiasis in individuals with depressed cell-mediated immunity (CMI), defects in CMI are viewed as a possible explanation for RVVC. In this review, we attempt to place into perspective the accumulated information regarding the immunopathogenesis of RVVC, as well as to provide new immunological perspectives and hypotheses regarding potential immunological deficiencies that may predispose to RVVC and potentially other mucosal infections by the same organism. The results of both clinical studies and studies in an animal model of experimental vaginitis suggest that systemic CMI may not be the predominant host defense mechanism against C. albicans vaginal infections. Rather, locally acquired mucosal immunity, distinct from that in the peripheral circulation, is now under consideration as an important host defense at the vaginal mucosa, as well as the notion that changes in local CMI mechanism(s) may predispose to RVVC.


This article has been cited by other articles:

  • Pietrella, D., Lupo, P., Rachini, A., Sandini, S., Ciervo, A., Perito, S., Bistoni, F., Vecchiarelli, A. (2008). A Candida albicans Mannoprotein Deprived of Its Mannan Moiety Is Efficiently Taken Up and Processed by Human Dendritic Cells and Induces T-Cell Activation without Stimulating Proinflammatory Cytokine Production. Infect. Immun. 76: 4359-4367 [Abstract] [Full Text]  
  • Vermitsky, J.-P., Self, M. J., Chadwick, S. G., Trama, J. P., Adelson, M. E., Mordechai, E., Gygax, S. E. (2008). Survey of Vaginal-Flora Candida Species Isolates from Women of Different Age Groups by Use of Species-Specific PCR Detection. J. Clin. Microbiol. 46: 1501-1503 [Abstract] [Full Text]  
  • Tsiodras, S., Samonis, G., Boumpas, D. T., Kontoyiannis, D. P. (2008). Fungal Infections Complicating Tumor Necrosis Factor {alpha} Blockade Therapy. Mayo Clin Proc. 83: 181-194 [Abstract] [Full Text]  
  • Cassone, A., De Bernardis, F., Santoni, G. (2007). Anticandidal Immunity and Vaginitis: Novel Opportunities for Immune Intervention. Infect. Immun. 75: 4675-4686 [Full Text]  
  • Febronio, M.V., Pereira, R.M.R., Bonfa, E., Takiuti, A.D., Pereyra, E.A.G., Silva, C.A.A. (2007). Inflammatory cervicovaginal cytology is associated with disease activity in juvenile systemic lupus erythematosus. Lupus 16: 430-435 [Abstract]  
  • LeBlanc, D. M., Barousse, M. M., Fidel, P. L. Jr. (2006). Role for Dendritic Cells in Immunoregulation during Experimental Vaginal Candidiasis.. Infect. Immun. 74: 3213-3221 [Abstract] [Full Text]  
  • Barousse, M. M., Espinosa, T., Dunlap, K., Fidel, P. L. Jr (2005). Vaginal Epithelial Cell Anti-Candida albicans Activity Is Associated with Protection against Symptomatic Vaginal Candidiasis. Infect. Immun. 73: 7765-7767 [Abstract] [Full Text]  
  • Richter, S. S., Galask, R. P., Messer, S. A., Hollis, R. J., Diekema, D. J., Pfaller, M. A. (2005). Antifungal Susceptibilities of Candida Species Causing Vulvovaginitis and Epidemiology of Recurrent Cases. J. Clin. Microbiol. 43: 2155-2162 [Abstract] [Full Text]  
  • Chami, F., Chami, N., Bennis, S., Trouillas, J., Remmal, A. (2004). Evaluation of carvacrol and eugenol as prophylaxis and treatment of vaginal candidiasis in an immunosuppressed rat model. J Antimicrob Chemother 54: 909-914 [Abstract] [Full Text]  
  • de Repentigny, L., Lewandowski, D., Jolicoeur, P. (2004). Immunopathogenesis of Oropharyngeal Candidiasis in Human Immunodeficiency Virus Infection. Clin. Microbiol. Rev. 17: 729-759 [Abstract] [Full Text]  
  • Sobel, J. D., Wiesenfeld, H. C., Martens, M., Danna, P., Hooton, T. M., Rompalo, A., Sperling, M., Livengood, C. III, Horowitz, B., Von Thron, J., Edwards, L., Panzer, H., Chu, T.-C. (2004). Maintenance Fluconazole Therapy for Recurrent Vulvovaginal Candidiasis. NEJM 351: 876-883 [Abstract] [Full Text]  
  • Sonnex, C (2004). Genital allergy. Sex. Transm. Infect. 80: 4-7 [Abstract] [Full Text]  
  • Deva, R., Shankaranarayanan, P., Ciccoli, R., Nigam, S. (2003). Candida albicans Induces Selectively Transcriptional Activation of Cyclooxygenase-2 in HeLa Cells: Pivotal Roles of Toll-Like Receptors, p38 Mitogen-Activated Protein Kinase, and NF-{kappa}B. J. Immunol. 171: 3047-3055 [Abstract] [Full Text]  
  • Chong, P. P., Lee, Y. L., Tan, B. C., Ng, K. P. (2003). Genetic relatedness of Candida strains isolated from women with vaginal candidiasis in Malaysia. J Med Microbiol 52: 657-666 [Abstract] [Full Text]  
  • Davis, D. A., Bruno, V. M., Loza, L., Filler, S. G., Mitchell, A. P. (2002). Candida albicans Mds3p, a Conserved Regulator of pH Responses and Virulence Identified Through Insertional Mutagenesis. Genetics 162: 1573-1581 [Abstract] [Full Text]  
  • Wozniak, K. L., Wormley, F. L. Jr., Fidel, P. L. Jr. (2002). Candida-Specific Antibodies during Experimental Vaginal Candidiasis in Mice. Infect. Immun. 70: 5790-5799 [Abstract] [Full Text]  
  • Santoni, G., Boccanera, M., Adriani, D., Lucciarini, R., Amantini, C., Morrone, S., Cassone, A., De Bernardis, F. (2002). Immune Cell-Mediated Protection against Vaginal Candidiasis: Evidence for a Major Role of Vaginal CD4+ T Cells and Possible Participation of Other Local Lymphocyte Effectors. Infect. Immun. 70: 4791-4797 [Abstract] [Full Text]  
  • Laprade, L., Boyartchuk, V. L., Dietrich, W. F., Winston, F. (2002). Spt3 Plays Opposite Roles in Filamentous Growth in Saccharomyces cerevisiae and Candida albicans and Is Required for C. albicans Virulence. Genetics 161: 509-519 [Abstract] [Full Text]  
  • De Bernardis, F., Boccanera, M., Adriani, D., Girolamo, A., Cassone, A. (2002). Intravaginal and Intranasal Immunizations Are Equally Effective in Inducing Vaginal Antibodies and Conferring Protection against Vaginal Candidiasis. Infect. Immun. 70: 2725-2729 [Abstract] [Full Text]  
  • Wormley, F. L. Jr., Chaiban, J., Fidel, P. L. Jr. (2001). Cell Adhesion Molecule and Lymphocyte Activation Marker Expression during Experimental Vaginal Candidiasis. Infect. Immun. 69: 5072-5079 [Abstract] [Full Text]  
  • El-Din, S S, Reynolds, M T, Ashbee, H R, Barton, R C, Evans, E G V (2001). An investigation into the pathogenesis of vulvo-vaginal candidosis. Sex. Transm. Infect. 77: 179-183 [Abstract] [Full Text]  
  • de Bernardis, F., Santoni, G., Boccanera, M., Spreghini, E., Adriani, D., Morelli, L., Cassone, A. (2000). Local Anticandidal Immune Responses in a Rat Model of Vaginal Infection by and Protection against Candida albicans. Infect. Immun. 68: 3297-3304 [Abstract] [Full Text]  
  • Braun, B. R., Johnson, A. D. (2000). TUP1, CPH1 and EFG1 Make Independent Contributions to Filamentation in Candida albicans. Genetics 155: 57-67 [Abstract] [Full Text]  
  • Carlson, P., Richardson, M., Paavonen, J. (2000). Evaluation of the Oricult-N Dipslide for Laboratory Diagnosis of Vaginal Candidiasis. J. Clin. Microbiol. 38: 1063-1065 [Abstract] [Full Text]  
  • Fidel, P. L. Jr., Cutright, J., Steele, C. (2000). Effects of Reproductive Hormones on Experimental Vaginal Candidiasis. Infect. Immun. 68: 651-657 [Abstract] [Full Text]  
  • Saavedra, M., Taylor, B., Lukacs, N., Fidel, P. L. Jr. (1999). Local Production of Chemokines during Experimental Vaginal Candidiasis. Infect. Immun. 67: 5820-5826 [Abstract] [Full Text]  
  • Fidel, P. L. Jr., Luo, W., Steele, C., Chabain, J., Baker, M., Wormley, F. Jr. (1999). Analysis of Vaginal Cell Populations during Experimental Vaginal Candidiasis. Infect. Immun. 67: 3135-3140 [Abstract] [Full Text]  
  • Fidel, P. L. Jr., Vazquez, J. A., Sobel, J. D. (1999). Candida glabrata: Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison to C. albicans. Clin. Microbiol. Rev. 12: 80-96 [Abstract] [Full Text]  
  • Han, Y., Morrison, R. P., Cutler, J. E. (1998). A Vaccine and Monoclonal Antibodies That Enhance Mouse Resistance to Candida albicans Vaginal Infection. Infect. Immun. 66: 5771-5776 [Abstract] [Full Text]  
  • Martinez, J. P., Gil, M. L., Lopez-Ribot, J. L., Chaffin, W. L. (1998). Serologic Response to Cell Wall Mannoproteins and Proteins of Candida albicans. Clin. Microbiol. Rev. 11: 121-141 [Abstract] [Full Text]  
  • Sobel, J. D. (1997). Vaginitis. NEJM 337: 1896-1903 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»